Recro Pharma REPH

$ 1.4 -4.76%

Annual report 2023
added 03-22-2024

Recro Pharma EV/EBITDA Ratio 2011-2025 | REPH

Annual EV/EBITDA Ratio Recro Pharma

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
13.4	-27.7	16.3	-4	-5.7	-2.11	-49.7	0.221	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16.3	-49.7	-7.42